Maryam Aalamian-Mattheis
- Omalizumab improves asthma in long term therapyBy Peter Kardos, Hassan Alakmeh, Christian Franke and Maryam Aalamian-MattheisPeter Kardos1Pneumologie, Zentrum für Allergologie, Pneumologie und Schlafmedizin am Maingau Krankenhaus, Frankfurt, GermanyHassan Alakmeh2Innere Medizin, Praxis Dr.med. Hassan Alakmeh, Backnang, GermanyChristian Franke3Pneumologie, Gemeinschaftspraxis Dres. Franke, Sonneberg, GermanyMaryam Aalamian-Mattheis4Clinical Research Critical Care, Novartis Pharma GmbH, Nuremberg, Germany
- Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING studyBy Jose Mª Marin, Andreas Clemens, Ricard Casamor, Walter Castellani, Lennart Schaper, Dinesh Saralaya, Anthony Gunstone, Konstantinos Kostikas, Maryam Aalamian-Mattheis and Kai BeehJose Mª Marin1Respiratory Medicine, Hospital Universitario Miguel Servet, University of Zaragoza School of Medicine, Zaragoza, SpainAndreas Clemens2Respiratory, Novartis Pharma AG, Basel, SwitzerlandRicard Casamor3Respiratory, Novartis Farmaceutica S.A., Barcelona, SpainWalter Castellani4Department of Respiratory Physiopathology, Ospedale Piero Palagi, Fiorenze, ItalyLennart Schaper5Studienpraxis, Research Practice, Berlin-Brandenburg, GermanyDinesh Saralaya6Respiratory Medicine, Bradford Royal Infirmary, Bradford, GermanyAnthony Gunstone7Staploe Medical Center, Staploe Medical Center, Soham, Cambridge, United KingdomKonstantinos Kostikas2Respiratory, Novartis Pharma AG, Basel, SwitzerlandMaryam Aalamian-Mattheis2Respiratory, Novartis Pharma AG, Basel, SwitzerlandKai Beeh8INSAF, Respiratory Research Institute, Wiesbaden, Germany
- Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrationsBy Claus Kroegel, Martin Foerster, Kristin Lerche, Maryam Aalamian-Mattheis, Janett Happe, Anne Moeser and Stephanie KornClaus Kroegel1Pneumology & Allergology/Immunology, University Clinics Jena, Jena, GermanyMartin Foerster1Pneumology & Allergology/Immunology, University Clinics Jena, Jena, GermanyKristin Lerche2Clinical Research, Novartis Pharma, Nürnberg, GermanyMaryam Aalamian-Mattheis2Clinical Research, Novartis Pharma, Nürnberg, GermanyJanett Happe1Pneumology & Allergology/Immunology, University Clinics Jena, Jena, GermanyAnne Moeser1Pneumology & Allergology/Immunology, University Clinics Jena, Jena, GermanyStephanie Korn3Pneumology, Johannes Gutenberg-University, Mainz, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
